Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20508478 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine
Condition: Pneumococcal Disease
Intervention: Biological: 10 valent pneumococcal conjugate (vaccine)

Indicates status has not been verified in more than two years